Search

everythinglearnresearchcommunity

for

Search:↓

Combining dutasteride mesotherapy with oral minoxidil is more effective for hair loss than using oral minoxidil alone.

Some gonadal hormone drugs can block filovirus entry into cells.

5-alpha reductase inhibitors may have additional effects on cancer, mental health, heart health, and hormone levels beyond treating prostate enlargement.

Cyproterone acetate with ethinyl estradiol is effective for treating skin symptoms related to high androgen levels, like in PCOS.

Ritlecitinib effectively treats severe Alopecia Areata by reducing harmful immune activity in the skin.

Combining imiquimod with diphenylcyclopropenone may improve treatment outcomes for alopecia areata patients who don't respond to diphenylcyclopropenone alone.

Upadacitinib effectively treated a patient with multiple inflammatory conditions.

Ritlecitinib improved hair regrowth and emotional well-being in some alopecia areata patients.

Cyproterone acetate is a safe treatment that causes modest feminization in transgender female adolescents, and works better with added estrogens.

Immunotherapy with pembrolizumab significantly reduced cancer in a young woman with adrenocortical carcinoma.

Certolizumab effectively treats psoriasis and psoriatic arthritis with fewer side effects than adalimumab.

PF-998425 is a new, effective, and non-phototoxic treatment for skin conditions related to androgens.

Different people with severe hair loss respond to baricitinib treatment at different times, with some showing improvement early, some gradually, and others later.

Baricitinib is effective and safe for treating severe alopecia areata.

New treatments for prostate cancer are less toxic and show promise, but more research is needed to enhance their effectiveness and reduce side effects.

Bifidobacterium longum BB536 metabolites may help treat hair loss by repairing and promoting hair cell growth.

Ritlecitinib effectively improves hair regrowth and physician satisfaction in severe alopecia areata over time.

Dutasteride is more effective than finasteride for hair loss, but more research is needed on safety and dosing.

Baricitinib effectively treats severe alopecia for up to 104 weeks.

A combination of desogestrel and ethinyl oestradiol effectively reduces hair growth in hirsute women.

Increasing the dose of baricitinib to 4 mg helps more patients with severe alopecia areata regrow hair.

Compound 7b is a promising candidate for treating benign prostatic hyperplasia and prostate cancer.

N-acetyl-GED may help prevent and partially reverse a process that leads to scarring hair loss.

Arachis hypogaea L. root extract reduces prostate enlargement and inflammation in mice.

Ritlecitinib is generally safe for long-term use, with mostly mild side effects.

Baricitinib is effective and safe for long-term treatment of severe alopecia areata.

Hormone treatments can help with women's skin and hair disorders, but they need careful monitoring and more research.